Bio-Rad Laboratories, Inc. Share Price
Equities
BIO
US0905722072
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 264.88 USD | +3.24% |
|
-10.99% | -11.88% |
| 13/02 | UBS Adjusts Price Target on Bio-Rad Laboratories to $335 From $350, Maintains Buy Rating | MT |
| 13/02 | Bio-Rad Laboratories, Inc., Q4 2025 Earnings Call, Feb 12, 2026 |
| Capitalization | 692.71Cr 585.69Cr 534.87Cr 512.05Cr 945.99Cr 63TCr 980.67Cr 6.24TCr 2.47TCr 30TCr 2.6TCr 2.54TCr 1,06400Cr | P/E ratio 2026 * |
34.5x | P/E ratio 2027 * | 32.2x |
|---|---|---|---|---|---|
| Enterprise value | 661Cr 558.88Cr 510.39Cr 488.61Cr 902.68Cr 60TCr 935.78Cr 5.95TCr 2.36TCr 29TCr 2.48TCr 2.43TCr 1,01500Cr | EV / Sales 2026 * |
2.52x | EV / Sales 2027 * | 2.33x |
| Free-Float |
64.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Bio-Rad Laboratories, Inc.
| 1 day | +3.37% | ||
| 1 week | -10.99% | ||
| Current month | -9.09% | ||
| 1 month | -14.63% | ||
| 3 months | -12.19% | ||
| 6 months | -6.20% | ||
| Current year | -11.88% |
| 1 week | 251 |  | 298.96 |
| 1 month | 251 | | 316.63 |
| Current year | 251 | | 328.56 |
| 1 year | 211.43 | | 343.12 |
| 3 years | 211.43 | | 509.62 |
| 5 years | 211.43 | | 832.7 |
| 10 years | 128.12 | | 832.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CEO | Chief Executive Officer | 75 | 01/01/2003 |
| President | 61 | 09/09/2024 | |
| Director of Finance/CFO | 55 | 15/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CHM | Chairman | 75 | 01/01/2012 |
Jeffrey Edwards
BRD | Director/Board Member | 65 | 25/04/2017 |
Gregory Hinckley
BRD | Director/Board Member | 79 | 25/04/2017 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -.--% | 1.9% | 2 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.24% | -10.99% | -5.72% | -44.75% | 692.71Cr | |
| -0.25% | -0.04% | -13.79% | +5.14% | 20TCr | |
| -2.59% | -4.81% | +12.16% | +13.84% | 13TCr | |
| -0.11% | +0.24% | +49.47% | +123.46% | 7.02TCr | |
| -0.04% | +0.13% | +42.33% | +100.00% | 6.04TCr | |
| +1.03% | +3.45% | -21.11% | -27.37% | 5.01TCr | |
| +2.66% | +0.91% | - | - | 3.71TCr | |
| +1.08% | +3.92% | -21.76% | -38.28% | 2.69TCr | |
| -0.41% | +1.24% | +12.77% | +30.61% | 2.44TCr | |
| -0.26% | -4.40% | -18.19% | -48.38% | 1.97TCr | |
| Average | +0.48% | -2.19% | +4.02% | +12.70% | 6.19TCr | |
| Weighted average by Cap. | -0.31% | -0.35% | +5.41% | +25.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 262.22Cr 221.71Cr 202.47Cr 193.84Cr 358.1Cr 24TCr 371.23Cr 2.36TCr 935.35Cr 11TCr 983.47Cr 963.17Cr 40TCr | 270.48Cr 228.69Cr 208.85Cr 199.94Cr 369.38Cr 25TCr 382.92Cr 2.44TCr 964.81Cr 12TCr 1.01TCr 993.51Cr 42TCr |
| Net income | 26Cr 22Cr 20Cr 19Cr 35Cr 2.33TCr 36Cr 231.49Cr 92Cr 1.12TCr 96Cr 94Cr 3.95TCr | 28Cr 24Cr 22Cr 21Cr 38Cr 2.53TCr 39Cr 251.3Cr 100Cr 1.22TCr 104.64Cr 102.48Cr 4.29TCr |
| Net Debt | -32Cr -27Cr -24Cr -23Cr -43Cr -2.87TCr -45Cr -285.64Cr -113.12Cr -1.39TCr -118.94Cr -116.48Cr -4.87TCr | -64Cr -54Cr -50Cr -47Cr -88Cr -5.82TCr -91Cr -578.48Cr -229.08Cr -2.81TCr -240.87Cr -235.9Cr -9.87TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/26/18 | 266.72 $ | +3.96% | 2,96,204 |
| 13/26/13 | 256.56 $ | -12.26% | 10,60,713 |
| 12/26/12 | 292.42 $ | -0.43% | 4,26,697 |
| 11/26/11 | 293.69 $ | -2.09% | 2,27,163 |
| 10/26/10 | 299.96 $ | +1.72% | 1,88,736 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BIO Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition